A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation
Clinical trial NCT02823470 · TERMINATED
Trial details
- NCT number
- NCT02823470
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.